Katz L Jay, Zangalli Camila, Clifford Raymond, Leiby Benjamin
Department of Ophthalmology (Dr Katz) and the Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics (Dr Leiby), Jefferson Medical College, Thomas Jefferson University; Wills Eye Institute (Dr Katz and Dr Zangalli); and Drexel University College of Medicine (Mr Clifford).
Trans Am Ophthalmol Soc. 2013 Sep;111:155-68.
To determine whether pupil enlargement during phacotrabeculectomy affects postoperative visual acuity and intraocular pressure (IOP) compared to combined surgery without pupil enlargement.
A retrospective study of 74 patients who underwent combined phacotrabeculectomy with (37 eyes) or without (37 eyes) pupil enlargement was performed. Postoperative outcome measures included best-corrected visual acuity (BCVA), IOP, number of medications, and complications up to 6 months. Wilcoxon-Mann-Whitney test was used to compare outcomes between groups.
Demographic characteristics of the two groups were similar except for diagnosis; chronic angle-closure glaucoma and pseudoexfoliation syndrome were more common in the pupil enlargement group. Preoperatively, the pupil enlargement group had a mean IOP of 21.2 ± 6.6 mm Hg compared to 21.1 ± 6.4 mm Hg for the control group (P=.978, Wilcoxon-Mann-Whitney test). Mean preoperative logMAR equivalent (BCVA) was 0.68 ± 0.67 and 0.63 ± 0.59, respectively (P=.727, Wilcoxon-Mann-Whitney test). At 6 months, mean IOP was 15.5 ± 5.6 mm Hg in the study group and 13.3 ± 4.5 mm Hg in the control group (P=.039, Wilcoxon-Mann-Whitney test). Mean postoperative vision at 6 months was better in the control group (0.36 ± 0.48) vs pupil enlargement group (0.51 ± 0.66) but not statistically different (P=.324 Wilcoxon-Mann-Whitney test). The groups did not differ in number of postoperative glaucoma medications. Complications were rare in both groups.
The results of this study suggest that the outcomes of combined phacoemulsification and trabeculectomy are not adversely impacted by pupil enlargement, although IOP control may be relatively impaired.
与未散瞳的联合手术相比,确定白内障小梁切除术期间瞳孔散大是否会影响术后视力和眼压(IOP)。
对74例行白内障小梁切除术联合散瞳(37只眼)或未散瞳(37只眼)的患者进行回顾性研究。术后观察指标包括最佳矫正视力(BCVA)、眼压、用药数量以及长达6个月的并发症情况。采用Wilcoxon-Mann-Whitney检验比较两组间的结果。
除诊断外,两组的人口统计学特征相似;慢性闭角型青光眼和假性剥脱综合征在瞳孔散大组更为常见。术前,瞳孔散大组的平均眼压为21.2±6.6mmHg,而对照组为21.1±6.4mmHg(P=0.978,Wilcoxon-Mann-Whitney检验)。术前平均对数最小分辨角等效值(BCVA)分别为0.68±0.67和0.63±0.59(P=0.727,Wilcoxon-Mann-Whitney检验)。在6个月时,研究组的平均眼压为15.5±5.6mmHg,对照组为13.3±4.5mmHg(P=0.039,Wilcoxon-Mann-Whitney检验)。对照组6个月时的术后平均视力(0.36±0.48)优于瞳孔散大组(0.51±0.66),但差异无统计学意义(P=0.324,Wilcoxon-Mann-Whitney检验)。两组术后青光眼用药数量无差异。两组并发症均少见。
本研究结果表明,尽管眼压控制可能相对受损,但白内障超声乳化联合小梁切除术的结果不会因瞳孔散大而受到不利影响。